Corcept Therapeutics Incorporated (BIT:1CORT)

Corcept Therapeutics Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 15, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	6,456	5,100	3,029	2,046	1,844	2,484
Market Cap Growth	109.94%	68.36%	48.06%	10.92%	-25.77%	101.63%
Enterprise Value	6,022	4,577	2,654	1,672	1,410	2,124
PE Ratio	57.44	37.78	31.74	21.59	18.64	28.67
PS Ratio	10.59	7.82	6.94	5.44	5.73	8.59
PB Ratio	11.93	7.77	6.61	4.36	5.58	5.81
P/TBV Ratio	11.93	7.77	6.61	4.36	5.58	5.81
P/FCF Ratio	42.06	26.95	26.38	18.23	12.53	20.16
P/OCF Ratio	41.62	26.66	26.36	18.17	12.49	20.00
EV/Sales Ratio	9.85	7.02	6.08	4.45	4.38	7.34
EV/EBITDA Ratio	66.83	34.40	27.08	15.69	12.73	20.18
EV/EBIT Ratio	69.51	34.60	27.34	15.87	12.88	20.26
EV/FCF Ratio	39.23	24.19	23.12	14.90	9.58	17.24
Debt / Equity Ratio	0.01	0.01	0	0.00	0.00	0.01
Debt / EBITDA Ratio	0.06	0.05	0.00	0.01	0.00	0.02
Debt / FCF Ratio	0.04	0.04	0.00	0.01	0.00	0.02
Asset Turnover	0.95	0.92	0.80	0.80	0.74	0.72
Inventory Turnover	1.18	1.08	0.94	0.97	1.07	1.08
Quick Ratio	2.81	3.11	4.05	6.60	5.31	9.86
Current Ratio	3.06	3.35	4.39	6.89	5.61	10.07
Return on Equity (ROE)	21.70%	23.81%	21.05%	23.11%	25.03%	23.70%
Return on Assets (ROA)	8.36%	11.71%	11.13%	13.98%	15.63%	16.29%
Return on Capital (ROIC)	10.19%	14.34%	13.28%	16.01%	17.25%	17.79%
Return on Capital Employed (ROCE)	15.40%	19.60%	20.80%	22.00%	33.10%	24.50%
Earnings Yield	1.74%	2.67%	3.17%	4.64%	5.36%	3.49%
FCF Yield	2.38%	3.71%	3.79%	5.48%	7.98%	4.96%
Buyback Yield / Dilution	-6.81%	-1.55%	3.64%	7.94%	-1.42%	-1.33%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.